Barriers to Accessing GLP-1s in the U.S.

Many Americans encounter difficulties in affording GLP-1 medications, even with some recent improvements. These barriers persist across the country, impacting a large number of individuals who depend on these treatments.

In response, numerous patients are turning toward unregulated alternatives. These versions often come at lower prices, presenting an attractive option for those in need.

This issue is part of a broader series titled GLP-1s: Reshaping America, reported by Stephanie Sy. Sy is a seasoned journalist, currently serving as a PBS News Hour correspondent. Her career includes roles at ABC News, Al Jazeera America, CNN International, and more. She notably anchored Yahoo News during the 2018 Midterm Elections and reported from Donald Trump’s 2016 victory party.

Sam Lane, a reporter and producer in PBS NewsHour’s segment unit, contributes to this series. Additionally, Mike Fritz, the deputy senior producer for field segments, plays a crucial role in bringing these stories to light.